OA-29 First Results from the Randomized Portion of a Phase 2 Study of Venetoclax Plus Carfilzomib-Dexamethasone Vs Carfilzomib-Dexamethasone in Patients with T(11;14) Relapsed/refractory Multiple Myeloma
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA(2023)
关键词
International Myeloma Working Group
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要